February 8, 2025 Week in Review: Trade Wars, Earnings, and Labor Data
February 4, 2025 AI Ventures Soar as Trade Tensions Heat Up – Key Weekly Highlights
Nvidia Stock: Evaluating Competitive Risks Amid Growth Prospects
Apple: Valuation Concerns Persist Amid Fundamental Strength
February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024
January 21, 2025 Trading Stocks With AI: A Modern Approach
January 21, 2025 Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025
January 1, 2025 Advanced Charting Tools For Traders
December 21, 2024 Why Is Trading Important?
Ocuphire Pharma (OCUP) stock forecast for 2026
Updated: February 10, 2025 (07:06)
Sector: HealthcareThe share price of Ocuphire Pharma, Inc. (OCUP) now
50/200 Day Moving Average: $ / $
This figure corresponds to the Average Price over the previous 50/200 days. For Ocuphire Pharma stocks, the 50-day moving average is the support level today.
For Ocuphire Pharma stocks, the 200-day moving average is the support level today.
Are you interested in Ocuphire Pharma, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Ocuphire Pharma stock price in 2026. How much will one Ocuphire Pharma share be worth in 2026? Is it worth taking profit / loss on OCUP stock now or waiting? What are analysts' forecasts for Ocuphire Pharma stock?
We forecast Ocuphire Pharma stock performance using neural networks based on historical data on OCUP stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Ocuphire Pharma, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Ocuphire Pharma analysts is $. Today 200 Day Moving Average is the support level ( $). 50 Day Moving Average is the support level ( $).
Historical and forecast chart of Ocuphire Pharma, Inc. stock
The chart below shows the historical price of Ocuphire Pharma stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the OCUP stock price can be found in the table below.
Ocuphire Pharma, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Farmington Hills, MI.
Ocuphire Pharma (OCUP) Forecast for 2026
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 0.94 | 0.85 | 1.00 | 14.81 % |
Feb | 0.96 | 0.87 | 0.99 | 12.20 % |
Mar | 0.99 | 0.94 | 1.09 | 12.98 % |
Apr | 1.00 | 0.93 | 1.10 | 15.71 % |
May | 1.12 | 1.05 | 1.22 | 13.82 % |
Jun | 1.06 | 0.98 | 1.10 | 11.26 % |
Jul | 1.12 | 1.08 | 1.16 | 7.37 % |
Aug | 1.15 | 1.10 | 1.23 | 10.97 % |
Sep | 1.20 | 1.13 | 1.23 | 8.11 % |
Oct | 1.08 | 0.97 | 1.14 | 14.71 % |
Nov | 0.97 | 0.87 | 1.04 | 15.75 % |
Dec | 0.99 | 0.91 | 1.03 | 11.72 % |
Ocuphire Pharma information and performance
N/A
Market capitalization of the Ocuphire Pharma, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of OCUP shares in the company outstanding by the market price of one share.
EBITDA of Ocuphire Pharma is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Ocuphire Pharma price target for 2026 by month
Target values for the price of one Ocuphire Pharma share for Jan 2026.
In Jan, the Negative dynamics for Ocuphire Pharma, Inc. shares will prevail with possible monthly volatility of 14.806% volatility is expected.
Pessimistic target level: 0.85
Optimistic target level: 1.00
Target values for the price of one Ocuphire Pharma share for Feb 2026.
In Feb, the Positive dynamics for Ocuphire Pharma, Inc. shares will prevail with possible monthly volatility of 12.198% volatility is expected.
Pessimistic target level: 0.87
Optimistic target level: 0.99
Target values for the price of one Ocuphire Pharma share for Mar 2026.
In Mar, the Positive dynamics for Ocuphire Pharma, Inc. shares will prevail with possible monthly volatility of 12.983% volatility is expected.
Pessimistic target level: 0.94
Optimistic target level: 1.09
Target values for the price of one Ocuphire Pharma share for Apr 2026.
In Apr, the Positive dynamics for Ocuphire Pharma, Inc. shares will prevail with possible monthly volatility of 15.710% volatility is expected.
Pessimistic target level: 0.93
Optimistic target level: 1.10
Target values for the price of one Ocuphire Pharma share for May 2026.
In May, the Positive dynamics for Ocuphire Pharma, Inc. shares will prevail with possible monthly volatility of 13.822% volatility is expected.
Pessimistic target level: 1.05
Optimistic target level: 1.22
Target values for the price of one Ocuphire Pharma share for Jun 2026.
In Jun, the Negative dynamics for Ocuphire Pharma, Inc. shares will prevail with possible monthly volatility of 11.261% volatility is expected.
Pessimistic target level: 0.98
Optimistic target level: 1.10
Target values for the price of one Ocuphire Pharma share for Jul 2026.
In Jul, the Positive dynamics for Ocuphire Pharma, Inc. shares will prevail with possible monthly volatility of 7.373% volatility is expected.
Pessimistic target level: 1.08
Optimistic target level: 1.16
Target values for the price of one Ocuphire Pharma share for Aug 2026.
In Aug, the Positive dynamics for Ocuphire Pharma, Inc. shares will prevail with possible monthly volatility of 10.973% volatility is expected.
Pessimistic target level: 1.10
Optimistic target level: 1.23
Target values for the price of one Ocuphire Pharma share for Sep 2026.
In Sep, the Positive dynamics for Ocuphire Pharma, Inc. shares will prevail with possible monthly volatility of 8.109% volatility is expected.
Pessimistic target level: 1.13
Optimistic target level: 1.23
Target values for the price of one Ocuphire Pharma share for Oct 2026.
In Oct, the Negative dynamics for Ocuphire Pharma, Inc. shares will prevail with possible monthly volatility of 14.705% volatility is expected.
Pessimistic target level: 0.97
Optimistic target level: 1.14
Target values for the price of one Ocuphire Pharma share for Nov 2026.
In Nov, the Negative dynamics for Ocuphire Pharma, Inc. shares will prevail with possible monthly volatility of 15.754% volatility is expected.
Pessimistic target level: 0.87
Optimistic target level: 1.04
Target values for the price of one Ocuphire Pharma share for Dec 2026.
In Dec, the Positive dynamics for Ocuphire Pharma, Inc. shares will prevail with possible monthly volatility of 11.718% volatility is expected.
Pessimistic target level: 0.91
Optimistic target level: 1.03
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.